Details of the Drug
General Information of Drug (ID: DMOCQ9I)
Drug Name |
N~3~-BENZYLPYRIDINE-2,3-DIAMINE
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
N3-benzylpyridine-2,3-diamine; 79707-12-3; N~3~-Benzylpyridine-2,3-Diamine; N3-BENZYL-PYRIDINE-2,3-DIAMINE; 2-amino-3-benzylaminopyridine; 3-N-benzylpyridine-2,3-diamine; N~3~-Benzyl-2,3-pyridinediamine; aminopyridine 3; N'-benzylpyridine-2,3-diamine; 2ohm; 2,3-Pyridinediamine, N3-(phenylmethyl)-; CHEMBL435747; SCHEMBL11069733; CTK5E7044; BDBM15781; DTXSID40439234; 3-Substituted 2-Aminopyridine 5; MUKAGFLFIMVSQN-UHFFFAOYSA-N; MolPort-008-154-365; ALBB-013372; ZINC10339550; 9869AE; AKOS005174206; MCULE-5416742943; DB07281
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 199.25 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 2 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 3 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 2 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 3 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||